CCEL Q4 2018 Earnings — Cryo-Cell International, Inc. Revenue & Financial Results | Market Cap Arena

CCELCryo-Cell International, Inc.

$26M

Q4 2018 Earnings

Healthcare Medical - Care Facilities

Income Statement

Revenue

$9M+32.7% YoY

Gross Profit

$6M68.9% margin

Operating Income

$2M24.8% margin

Net Income

$890,75810.4% margin

EPS (Diluted)

$0.11

QoQ Revenue Growth

+9.2%

Cash Flow

Operating Cash Flow

$843,988

Free Cash Flow

$806,122

Stock-Based Comp.

$154,580

Balance Sheet

Total Assets

$42M

Total Liabilities

$51M

Stockholders' Equity

-$9M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$6M	+32.7%
Gross Profit	$6M	$5M	+22.4%
Operating Income	$2M	$1M	+71.2%
Net Income	$890,758	$679,218	+31.1%

Revenue Segments

Licensee And Royalty Income Recognition

$257,555100%